Clinical Trial Detail

NCT ID NCT03322566
Title Pembrolizumab Plus Epacadostat Alone or With Platinum-based Chemotherapy Versus Pembrolizumab Plus Platinum-based Chemotherapy Plus Placebo in Metastatic Non-Small Cell Lung Cancer
Recruitment Active, not recruiting
Gender
Phase Phase III
Variant Requirements yes
Sponsors Incyte Corporation
Indications

non-small cell lung carcinoma

Therapies

Epacadostat + Pembrolizumab

Paclitaxel + Carboplatin

Cisplatin + Pemetrexed

Carboplatin + Pemetrexed

Age Groups:

Additional content available in CKB BOOST